(Q46209254)

20 December 2017

title

Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls (English)

1 reference

20 December 2017

0 references

0 references

2

1 reference

20 December 2017

Harald Hampel

series ordinal

5

object named as

Harald Hampel

1 reference

20 December 2017

3

Stefan J Teipel

1 reference

20 December 2017

4

Katharina Buerger

1 reference

20 December 2017

Markus Ludwig Rupert Schwarz

series ordinal

1

object named as

Markus J Schwarz

1 reference

20 December 2017

publication date

29 November 2012

1 reference

20 December 2017

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

20 December 2017

volume

263

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

345-352

1 reference

20 December 2017

Alternative excitotoxic hypotheses

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Kynurenine metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Tryptophan depletion and its implications for psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

21 January 2018

Excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Depressive symptoms, sex, and risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Diclofenac increases the accumulation of kynurenate following tryptophan pretreatment in the rat: a possible factor contributing to its antihyperalgesic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Quinolinic acid, the inescapable neurotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Expression of the kynurenine pathway enzymes in human microglia and macrophages

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

21 January 2018

12 December 2020

A beta 1-42 induces production of quinolinic acid by human macrophages and microglia

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Characterization of the kynurenine pathway in human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Kynurenine and its metabolites in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Selective blockade of non-NMDA receptors does not block rapidly triggered glutamate-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Inflammatory processes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Neurochemical studies of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

The excitotoxin quinolinic acid induces tau phosphorylation in human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Cytokines and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

The kynurenine pathway of tryptophan degradation as a drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Generate Hydrogen Peroxide and Promote α-Crystallin Cross-Linking by Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-012-0384-X

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

21 January 2018

1 reference

12 December 2020

Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation

1 reference

12 December 2020

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

12 December 2020

1 reference

12 December 2020

3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity

1 reference

12 December 2020

3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum

1 reference

12 December 2020

Neuroexcitation, excitotoxicity and human neurological disease.

1 reference

12 December 2020

Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line

1 reference

12 December 2020

10.1007/S00406-012-0384-X

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017